RetinalGenix Technologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '25 Nov 4, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	60	60	95	54	155	-
Market Cap Growth	-	-37.25%	74.56%	-65.04%	-	-
Enterprise Value	60	60	95	55	156	-
Last Close Price	3.20	3.20	5.25	3.09	9.00	-
PB Ratio	-25.86	-25.86	-64.86	-38.66	-145.41	-
Debt / Equity Ratio	-0.24	-0.24	-0.36	-0.36	-0.15	-0.16
Net Debt / Equity Ratio	-0.23	-0.23	-0.35	-0.36	-0.15	-0.15
Net Debt / EBITDA Ratio	-0.22	-0.22	-0.12	-0.24	-0.08	-
Net Debt / FCF Ratio	-0.95	-0.95	-0.70	-1.12	-0.79	-0.06
Quick Ratio	0.01	0.01	0.00	-	0	0.01
Current Ratio	0.01	0.01	0.00	-	0	0.01
Return on Assets (ROA)	-8421.99%	-8421.99%	-35731.92%	-579736.00%	-44750.99%	-4121.12%
Return on Capital Employed (ROCE)	105.50%	105.50%	296.50%	148.50%	175.50%	468.40%
Earnings Yield	-4.08%	-4.08%	-4.55%	-3.85%	-2.52%	-
FCF Yield	-	-0.94%	-0.78%	-0.83%	-0.13%	-
Buyback Yield / Dilution	-3.47%	-3.47%	-3.39%	-11.34%	62.22%	-3.91%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.